Plasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program

Joanna Mitri; Jason Nelson; Robin Ruthazer; Cheryl Garganta; David M. Nathan; Frank B Hu; Bess Dawson‐Hughes; Anastassios G. Pittas

doi:10.1038/ejcn.2013.293

Related publications

Article2015

Association between body weight and composition and plasma 25-hydroxyvitamin D level in the Diabetes Prevention Program

Lisa Ceglia, Jason Nelson, James S. Ware, Konstantinos–Dionysios Alysandratos, George A. Bray, Cheryl Garganta, David M. Nathan, Frank B Hu, Bess Dawson‐Hughes, Anastassios G. Pittas

Article2012

Plasma 25-Hydroxyvitamin D and Progression to Diabetes in Patients at Risk for Diabetes

Anastassios G. Pittas, Jason Nelson, Joanna Mitri, William Hillmann, Cheryl Garganta, David M. Nathan, Frank B Hu, Bess Dawson‐Hughes

Article2008

Maternal Plasma 25-Hydroxyvitamin D Concentrations and the Risk for Gestational Diabetes Mellitus

CUILIN ZHANG, Chunfang Qiu, Frank B Hu, Robert David, Rob M. van Dam, Alexander Bralley, Michelle A. Williams

Article2010

Plasma 25-Hydroxyvitamin D Concentration and Risk of Incident Type 2 Diabetes in Women

Anastassios G. Pittas, Qi Sun, JoAnn E. Manson, Bess Dawson‐Hughes, Frank B Hu

Preprint2015

A prospective study of plasma 25-hydroxyvitamin D and parathyroid hormone concentrations and prostate cancer risk

Mélanie Deschasaux, Jean-Claude Souberbielle, Paule Latino‐Martel, Angéla Sutton, Nathalie Charnaux, Pilar Galán, Serge Hercberg, Emmanuelle Kesse‐Guyot, Khaled Ezzedine, Mathilde Touvier